BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38528604)

  • 1. Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study.
    Nguyen HB; Vo LNQ; Forse RJ; Wiemers AMC; Huynh HB; Dong TTT; Phan YTH; Creswell J; Dang TMH; Nguyen LH; Shedrawy J; Lönnroth K; Nguyen TD; Dinh LV; Annerstedt KS; Codlin AJ
    Infect Dis Poverty; 2024 Mar; 13(1):27. PubMed ID: 38528604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socio-protective effects of active case finding on catastrophic costs from tuberculosis in Ho Chi Minh City, Viet Nam: a longitudinal patient cost survey.
    Vo LNQ; Forse RJ; Codlin AJ; Dang HM; Van Truong V; Nguyen LH; Nguyen HB; Nguyen NV; Sidney-Annerstedt K; Lonnroth K; Squire SB; Caws M; Worrall E; de Siqueira-Filha NT
    BMC Health Serv Res; 2021 Oct; 21(1):1051. PubMed ID: 34610841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Nhung NV; Hoa NB; Anh NT; Anh LTN; Siroka A; Lönnroth K; Garcia Baena I
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):983-990. PubMed ID: 30092862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies.
    Ghazy RM; Sallam M; Ashmawy R; Elzorkany AM; Reyad OA; Hamdy NA; Khedr H; Mosallam RA
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
    Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
    Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal.
    Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT
    Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
    Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
    BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Tuberculosis With Household Catastrophic Expenditure in South India.
    Muniyandi M; Thomas BE; Karikalan N; Kannan T; Rajendran K; Saravanan B; Vohra V; Okorosobo T; Lönnroth K; Tripathy SP
    JAMA Netw Open; 2020 Feb; 3(2):e1920973. PubMed ID: 32049293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Private Sector Engagement for Tuberculosis Diagnosis and Reporting through an Intermediary Agency in Ho Chi Minh City, Viet Nam.
    Vo LNQ; Codlin AJ; Huynh HB; Mai TDT; Forse RJ; Truong VV; Dang HMT; Nguyen BD; Nguyen LH; Nguyen TD; Nguyen HB; Nguyen NV; Caws M; Lonnroth K; Creswell J
    Trop Med Infect Dis; 2020 Sep; 5(3):. PubMed ID: 32937757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the yield of systematic screening for tuberculosis among three priority groups in Ho Chi Minh City, Viet Nam.
    Vo LNQ; Codlin AJ; Forse RJ; Nguyen NT; Vu TN; Le GT; Van Truong V; Do GC; Dang HM; Nguyen LH; Nguyen HB; Nguyen NV; Levy J; Lonnroth K; Squire SB; Caws M
    Infect Dis Poverty; 2020 Dec; 9(1):166. PubMed ID: 33292638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
    Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
    Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequity in catastrophic costs among tuberculosis-affected households in China.
    Xu CH; Jeyashree K; Shewade HD; Xia YY; Wang LX; Liu Y; Zhang H; Wang L
    Infect Dis Poverty; 2019 Jun; 8(1):46. PubMed ID: 31215476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers.
    Muttamba W; Tumwebaze R; Mugenyi L; Batte C; Sekibira R; Nkolo A; Katamba A; Kasasa S; Majwala RK; Turyahabwe S; Mugabe F; Mugagga K; Lochoro P; Dejene S; Birabwa E; Marra C; Baena IG; Kirenga B
    BMC Public Health; 2020 Sep; 20(1):1409. PubMed ID: 32938411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Catastrophic Costs Due to Tuberculosis in Myanmar.
    Aung ST; Thu A; Aung HL; Thu M
    Trop Med Infect Dis; 2021 Jul; 6(3):. PubMed ID: 34287379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of patient costs associated with tuberculosis diagnosis and care in Solomon Islands.
    Viney K; Itogo N; Yamanaka T; Jebeniani R; Hazarika A; Morishita F; Nishikiori N; Nery SV
    BMC Public Health; 2021 Oct; 21(1):1928. PubMed ID: 34688266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
    Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
    PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing private provider perceptions and the acceptability of video observed treatment technology for tuberculosis treatment adherence in three cities across Viet Nam.
    Nguyen LH; Tran PTM; Dam TA; Forse RJ; Codlin AJ; Huynh HB; Dong TTT; Nguyen GH; Truong VV; Dang HTM; Nguyen TD; Nguyen HB; Nguyen NV; Khan A; Creswell J; Vo LNQ
    PLoS One; 2021; 16(5):e0250644. PubMed ID: 33961645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.